| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |